Novavax Offers U.S. a Fourth Strong Covid-19 Vaccine June 14, 2021 IFTTT NYT NYT > Business NYTimes The company’s large U.S. trial found an efficacy rate of about 90 percent. But at this point the nation is awash in other shots. +